Literature DB >> 31119637

Female Mouse Model of Neisseria gonorrhoeae Infection.

Erica L Raterman1, Ann E Jerse2.   

Abstract

Mouse models of infection are important tools in the study of infectious disease or host the development of products to prevent or treat infections. The estradiol-treated mouse model of Neisseria gonorrhoeae genital tract infection has proved to be a valuable system for determining the importance of gonococcal factors that mediate evasion of host innate effectors in vivo or host gonococcal adaptation to hormonally driven host factors in females. Examination of mechanisms that Neisseria gonorrhoeae uses to subvert the host immune response also has been greatly aided by this whole model system, as have studies on the consequence of antibiotic resistance mutations on gonococcal fitness in vivo and the search for new antibiotics to treat antibiotic-resistant infections. The strict human specificity of N. gonorrhoeae limits the ability of experimental murine infection to mimic human infection. However, in recent years, the development of transgenic mice and protocols for supplementing mice with human factors has improved animal modeling of gonorrhea. To date, however, because the mouse estrous cycle is much shorter than the human reproductive cycle, all reported gonorrhea mouse models require treatment with estradiol and antibiotics to maintain an estrus-like state and suppress the overgrowth of inhibitory commensal flora that occurs under the influence of estrogen to allow sustained N. gonorrhoeae infection. In this chapter, we detail the methods used to (1) prepare the mice for experimental infection with N. gonorrhoeae, (2) inoculate mice and quantitatively culture vaginal swabs for noncompetitive and competitive infection experiments, and (3) monitor the host innate immune response to infection.

Entities:  

Keywords:  Chemokines; Cytokines; Estradiol; Estrous cycle; Female mouse model of gonorrhea infection; Neisseria gonorrhoeae; Polymorphonuclear leukocytes

Mesh:

Substances:

Year:  2019        PMID: 31119637     DOI: 10.1007/978-1-4939-9496-0_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  In vivo efficacy of acetazolamide in a mouse model of Neisseria gonorrhoeae infection.

Authors:  Nader S Abutaleb; Ahmed E M Elhassanny; Mohamed N Seleem
Journal:  Microb Pathog       Date:  2022-02-19       Impact factor: 3.738

2.  The role of estrogen in circular RNA and metabonomics in a Neisseria gonorrhoeae infection model.

Authors:  Guiyue Cai; Jin Long; Ruitao Zou; Huizhi Yang; Jiahao Xie; Chunchan Zheng; Xiaoxuan Chen; Shuang Liu; Rongyi Chen
Journal:  Ann Transl Med       Date:  2022-09

Review 3.  Towards a deeper understanding of the vaginal microbiota.

Authors:  Michael France; Madeline Alizadeh; Sarah Brown; Bing Ma; Jacques Ravel
Journal:  Nat Microbiol       Date:  2022-03-04       Impact factor: 30.964

4.  Experimental Urethral Infection with Neisseria gonorrhoeae.

Authors:  Andreea Waltmann; Joseph A Duncan; Gerald B Pier; Colette Cywes-Bentley; Myron S Cohen; Marcia M Hobbs
Journal:  Curr Top Microbiol Immunol       Date:  2022-03-05       Impact factor: 4.737

5.  A Single Amino Acid Substitution in Elongation Factor G Can Confer Low-Level Gentamicin Resistance in Neisseria gonorrhoeae.

Authors:  Concerta L Holley; Vijaya Dhulipala; Jacqueline T Balthazar; Adriana Le Van; Afrin A Begum; Shao-Chun Chen; Timothy D Read; Mitch Matoga; Irving F Hoffman; Daniel Golparian; Magnus Unemo; Ann E Jerse; William M Shafer
Journal:  Antimicrob Agents Chemother       Date:  2022-04-25       Impact factor: 5.938

Review 6.  The role of vaccines in combatting antimicrobial resistance.

Authors:  Francesca Micoli; Fabio Bagnoli; Rino Rappuoli; Davide Serruto
Journal:  Nat Rev Microbiol       Date:  2021-02-04       Impact factor: 60.633

7.  Ribonucleotide reductase, a novel drug target for gonorrhea.

Authors:  Jana Narasimhan; Suzanne Letinski; Stephen P Jung; Aleksey Gerasyuto; Jiashi Wang; Michael Arnold; Guangming Chen; Jean Hedrick; Melissa Dumble; Kanchana Ravichandran; Talya Levitz; Chang Cui; Catherine L Drennan; JoAnne Stubbe; Gary Karp; Arthur Branstrom
Journal:  Elife       Date:  2022-02-09       Impact factor: 8.140

8.  Auranofin exerts antibacterial activity against Neisseria gonorrhoeae in a female mouse model of genital tract infection.

Authors:  Ahmed E M Elhassanny; Nader S Abutaleb; Mohamed N Seleem
Journal:  PLoS One       Date:  2022-04-21       Impact factor: 3.240

9.  Three-dimensional models of the cervicovaginal epithelia to study host-microbiome interactions and sexually transmitted infections.

Authors:  Vonetta L Edwards; Elias McComb; Jason P Gleghorn; Larry Forney; Patrik M Bavoil; Jacques Ravel
Journal:  Pathog Dis       Date:  2022-08-27       Impact factor: 3.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.